Great News! ENHERTU Approved in the U.S. as First HER2 Directed Therapy for Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following Disease Progression After One or More Endocrine Therapies. $AZN $DSNKY @RobertKennedyJr @FDAOncology @NIH